{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T16:54:27Z","timestamp":1778950467979,"version":"3.51.4"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,3]]},"DOI":"10.7759\/cureus.17675","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T16:36:22Z","timestamp":1630946182000},"source":"Crossref","is-referenced-by-count":1,"title":["Dermatofibrosarcoma Protuberans Presenting in a Patient With Neurofibromatosis Type 1: Potential Implications on Treatment"],"prefix":"10.7759","author":[{"given":"Bianca N","family":"Eubanks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawood A","family":"Tafti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"House","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Logemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Dermatofibrosarcoma protuberans","author":"Brooks J","year":"2021","unstructured":"Brooks J, Ramsey ML. Dermatofibrosarcoma protuberans. StatPearls Publishing, Treasure Island, FL; 2021."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2019.01.002","article-title":"Neurofibromatosis type 1: state-of-the-art review with emphasis on pulmonary involvement","volume":"149","author":"Alves J\u00fanior SF","year":"2019","unstructured":"Alves J\u00fanior SF, Zanetti G, Alves de Melo AS, et al.. Neurofibromatosis type 1: state-of-the-art review with emphasis on pulmonary involvement. Respir Med. 2019, 149:9-15. 10.1016\/j.rmed.2019.01.002","journal-title":"Respir Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2010.12.056","article-title":"The pathoetiology of neurofibromatosis 1","volume":"178","author":"Jouhilahti EM","year":"2011","unstructured":"Jouhilahti EM, Peltonen S, Heape AM, Peltonen J. The pathoetiology of neurofibromatosis 1. Am J Pathol. 2011, 178:1932-9. 10.1016\/j.ajpath.2010.12.056","journal-title":"Am J Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-009-0550-3","article-title":"Current treatment options in dermatofibrosarcoma protuberans","volume":"135","author":"Lemm D","year":"2009","unstructured":"Lemm D, M\u00fcgge LO, Mentzel T, H\u00f6ffken K. Current treatment options in dermatofibrosarcoma protuberans. J Cancer Res Clin Oncol. 2009, 135:653-65. 10.1007\/s00432-009-0550-3","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70414-X","article-title":"Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial","volume":"13","author":"Robertson KA","year":"2012","unstructured":"Robertson KA, Nalepa G, Yang FC, et al.. Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial. Lancet Oncol. 2012, 13:1218-24. 10.1016\/S1470-2045(12)70414-X","journal-title":"Lancet Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.4940","article-title":"Imatinib treatment for locally advanced or metastatic dermatofibrosarcoma protuberans: a systematic review","volume":"155","author":"Navarrete-Dechent C","year":"2019","unstructured":"Navarrete-Dechent C, Mori S, Barker CA, Dickson MA, Nehal KS. Imatinib treatment for locally advanced or metastatic dermatofibrosarcoma protuberans: a systematic review. JAMA Dermatol. 2019, 155:361-9. 10.1001\/jamadermatol.2018.4940","journal-title":"JAMA Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/68890-dermatofibrosarcoma-protuberans-presenting-in-a-patient-with-neurofibromatosis-type-1-potential-implications-on-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:28:56Z","timestamp":1707506936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/68890-dermatofibrosarcoma-protuberans-presenting-in-a-patient-with-neurofibromatosis-type-1-potential-implications-on-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":6,"URL":"https:\/\/doi.org\/10.7759\/cureus.17675","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,3]]}}}